‘Real-world’ management and outcomes of patients with paroxysmal vs. non-paroxysmal atrial fibrillation in Europe: the EURObservational Research Programme–Atrial Fibrillation (EORP-AF) General Pilot Registry
出版年份 2016 全文链接
标题
‘Real-world’ management and outcomes of patients with paroxysmal vs. non-paroxysmal atrial fibrillation in Europe: the EURObservational Research Programme–Atrial Fibrillation (EORP-AF) General Pilot Registry
作者
关键词
-
出版物
EUROPACE
Volume 18, Issue 5, Pages 648.1-657
出版商
Oxford University Press (OUP)
发表日期
2016-01-30
DOI
10.1093/europace/euv390
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Asymptomatic Atrial Fibrillation: Clinical Correlates, Management, and Outcomes in the EORP-AF Pilot General Registry
- (2015) Giuseppe Boriani et al. AMERICAN JOURNAL OF MEDICINE
- Non-valvular atrial fibrillation
- (2015) Giuseppe Boriani et al. Journal of Cardiovascular Medicine
- ‘Real-World’ Antithrombotic Treatment in Atrial Fibrillation: The EORP-AF Pilot Survey
- (2014) Gregory Y.H. Lip et al. AMERICAN JOURNAL OF MEDICINE
- Regional differences in presentation and treatment of patients with atrial fibrillation in Europe: a report from the EURObservational Research Programme Atrial Fibrillation (EORP-AF) Pilot General Registry
- (2014) G. Y. H. Lip et al. EUROPACE
- Sex-related differences in presentation, treatment, and outcome of patients with atrial fibrillation in Europe: a report from the Euro Observational Research Programme Pilot survey on Atrial Fibrillation
- (2014) Gregory Y.H. Lip et al. EUROPACE
- Higher risk of death and stroke in patients with persistent vs. paroxysmal atrial fibrillation: results from the ROCKET-AF Trial
- (2014) B. A. Steinberg et al. EUROPEAN HEART JOURNAL
- Risk of ischaemic stroke according to pattern of atrial fibrillation: analysis of 6563 aspirin-treated patients in ACTIVE-A and AVERROES
- (2014) T. Vanassche et al. EUROPEAN HEART JOURNAL
- Prognosis and treatment of atrial fibrillation patients by European cardiologists: One Year Follow-up of the EURObservational Research Programme-Atrial Fibrillation General Registry Pilot Phase (EORP-AF Pilot registry)
- (2014) Gregory Y.H. Lip et al. EUROPEAN HEART JOURNAL
- AF burden is important - fact or fiction?
- (2014) G. Boriani et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- A prospective survey in European Society of Cardiology member countries of atrial fibrillation management: baseline results of EURObservational Research Programme Atrial Fibrillation (EORP-AF) Pilot General Registry
- (2013) Gregory Y.H. Lip et al. EUROPACE
- Device-detected atrial fibrillation and risk for stroke: an analysis of >10 000 patients from the SOS AF project (Stroke preventiOn Strategies based on Atrial Fibrillation information from implanted devices)
- (2013) Giuseppe Boriani et al. EUROPEAN HEART JOURNAL
- Outcomes of apixaban vs. warfarin by type and duration of atrial fibrillation: results from the ARISTOTLE trial
- (2013) Sana M. Al-Khatib et al. EUROPEAN HEART JOURNAL
- Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials
- (2013) Christian T Ruff et al. LANCET
- Pattern of atrial fibrillation and risk of outcomes: The Loire Valley Atrial Fibrillation Project
- (2012) Amitava Banerjee et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)
- (2010) et al. EUROPACE
- Should we abandon the common practice of withholding oral anticoagulation in paroxysmal atrial fibrillation?
- (2008) R. Nieuwlaat et al. EUROPEAN HEART JOURNAL
- Stroke event rates in anticoagulated patients with paroxysmal atrial fibrillation
- (2008) G. Y. H. Lip et al. JOURNAL OF INTERNAL MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started